Bosentan and sildenafil in the treatment of HIV-associated pulmonary hypertension
We present the case of an HIV/HCV-coinfected patient with HIV-related pulmonary hypertension (HRPH) who experienced a good clinical and functional response to bosentan, with a subsequent switch to oral sildenafil due to increased transaminase levels. Bosentan resulted less handy in this case, probably due to both side effects and co-morbidities.
bosentan; sildenafil; HIV; pulmonary arterial hypertension
Submitted: 2011-08-11 17:47:31
Published: 2011-11-22 14:19:00
Search for citations in Google Scholar
Related articles: Google Scholar